Clinical trial EMBER
A Phase 1a/1b Study of LY3484356 Administered as Monotherapy and in Combination with Therapies for Patients with ER+, HER2-Locally Advanced or Metastatic Breast Cancer and Other Select Non-Breast Cancers
| Cancers | |
|---|---|
| Organ | Multiple |
| Trial status | Trial closed for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1/1b |
| Academic trial | Non |
| Sponsor | Lilly |
| EudraCT Identifier | 2019-003581-41 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT04188548 |
| Last update |